Physiological basis of fatigue (original) (raw)

Abstract

Evans WJ, Lambert CP: Physiological basis of fatigue. Am J Phys Med Rehabil 2007;86(Suppl):S29 -S46.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (143)

  1. Patrick DL, Ferketich SL, Frame PS, et al: National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, De- pression Fatigue, July 15-17, 2002. J Natl Cancer Inst 2003;95:1110-7
  2. Cella D, Lai JS, Chang CH, et al: Fatigue in cancer patients compared with fatigue in the general United States popu- lation. Cancer 2002;94:528-38
  3. Cella D, Peterman A, Passik S, et al: Progress toward guidelines for the management of fatigue. Oncology (Hun- tington) 1998;12:369-77
  4. Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43
  5. Evans WJ, Winsmann FR, Pandolf KB, et al: Self-paced hard work comparing men and women. Ergonomics 1980; 23:613-21
  6. Ekblom B: Factors determining maximal aerobic power. Acta Physiol Scand Suppl 1986;556:15-9
  7. Ekblom B, Goldbarg AN, Gullbring B: Response to exercise after blood loss and reinfusion. J Appl Physiol 1972;33: 175-80
  8. Ekblom B, Wilson G, Astrand PO: Central circulation dur- ing exercise after venesection and reinfusion of red blood cells. J Appl Physiol 1976;40:379-83
  9. Cook JD, Skikne BS, Baynes RD: Iron deficiency: the global perspective. Adv Exp Med Biol 1994;356:219-28
  10. Berglund B, Ekblom B: Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991;229:125-30
  11. Ribeiro JP, Fielding RA, Hughes V, et al: Heart rate break point may coincide with the anaerobic and not the aerobic threshold. Int J Sportsmed 1985;6:45-53
  12. Ribeiro JP, Hughes V, Fielding RA, et al: Metabolic and ventilatory responses to steady state exercise relative to lactate thresholds. Eur J Appl Physiol Occup Physiol 1986; 55:215-21
  13. Bergstrom J, Hermansen L, Huyltman E, et al: Diet-mus- cle glycogen and physical performance. Acta Physiol Scand 1967;71:140-50
  14. Bergstrom J, Hultman E: A study of the glycogen metab- olism during exercise in man. Scand J Clin Lab Invest 1967;19:218-28
  15. Bergstrom J, Hultman E: Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man. Nat Lond 1966;210:309-10
  16. Baldwin J, Snow RJ, Gibala MJ, et al: Glycogen availability does not affect the TCA cycle or TAN pools during pro- longed, fatiguing exercise J Appl Physiol 2003;94:2181-7
  17. Lees SJ, Franks PD, Spangenburg EE, et al: Glycogen and glycogen phosphorylase associated with sarcoplasmic reticulum: effects of fatiguing activit J Appl Physiol 2001; 91:1638-44
  18. Armstrong LE, Costill DL, Fink WJ: Influence of dehydra- tion on competitive running performance. Med Sci Sports Exerc 1985;17:456-61
  19. Montain SJ, Smith SA, Mattot RP, et al: Hypohydration effects on skeletal muscle performance and metabolism: a 31P-MRS study. J Appl Physiol 1998;84:1889-94
  20. Gonzalez-Alonso J, Calbet JA, Nielsen B: Metabolic and thermodynamic responses to dehydration-induced reduc- tions in muscle blood flow in exercising humans. J Physiol 1999;520:577-89
  21. Pfeifer M, Begerow B, Minne HW: Vitamin D and muscle function. Osteoporos Int 2002;13:187-94
  22. Visser M, Deeg DJ, Lips P: Low vitamin D and high para- thyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88:5766-72
  23. Bischoff HA, Stahelin HB, Dick W, et al: Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51
  24. Bischoff HA, Stahelin HB, Urscheler N, et al: Muscle strength in the elderly: its relation to vitamin D metabo- lites. Arch Phys Med Rehabil 1999;80:54-8
  25. Vaz M, Thangam , Prabhu A, et al: Maximal voluntary contraction as a functional indicator of adult chronic undernutrition. Br J Nutr 1996;76:9-15
  26. Thompson A, Damyanovich A, Madapallimattam A, et al: 31P-nuclear magnetic resonance studies of bioenergetic changes in skeletal muscle in malnourished human adults. Am J Clin Nutr 1998;67:39-43
  27. Bissonnette DJ, Madapallimatam A, Jeejeebhoy KN: Effect of hypoenergetic feeding and high-carbohydrate refeeding on muscle tetanic tension, relaxation rate, and fatigue in slow-and fast-twitch muscles in rats. Am J Clin Nutr 1997;66:293-303
  28. Lepers R, Hausswirth C, Maffiuletti N, et al: Evidence of neuromuscular fatigue after prolonged cycling exercise. Med Sci Sports Exerc 2000;32:1880-6
  29. Lepers R, Maffiuletti NA, Rochette L, et al: Neuromuscular fatigue during a long-duration cycling exercise. J Appl Physiol 2002;92:1487-93
  30. Millet GY, Lepers R: Alterations of neuromuscular func- tion after prolonged running, cycling and skiing exercises. Sports Med 2004;34:105-16
  31. Millet GY, Lepers R, Maffiuletti NA, et al: Alterations of neuromuscular function after an ultramarathon. J Appl Physiol 2002;92:486-92
  32. Place N, Lepers R, Deley G, et al: Time course of neuro- muscular alterations during a prolonged running exercise. Med Sci Sports Exerc 2004;36:1347-56
  33. Nybo L, Nielsen B: Hyperthermia and central fatigue dur- ing prolonged exercise in humans. J Appl Physiol 2001; 91:1055-60
  34. Nybo L: CNS fatigue and prolonged exercise: effect of glucose supplementation. Med Sci Sports Exerc 2003;35: 589-94
  35. Bentley DJ, Smith PA, Davie AJ, et al: Muscle activation of the knee extensors following high intensity endurance exercise in cyclists. Eur J Appl Physiol 2000;81:297-302
  36. Gilliam PE, Spirduso WW, Martin TP, et al: The effects of exercise training on [3H]-spiperone binding in rat stria- tum. Pharmacol Biochem Behav 1984;20:863-7
  37. Meeusen R, Thorre K, Chaouloff F, et al: Effects of tryp- tophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Res 1996;740:245-52
  38. Heyes MP, Garnett ES, Coates G: Nigrostriatal dopaminer- gic activity is increased during exhaustive exercise stress in rats. Life Sci 1988;42:1537-42
  39. Hattori S, Naoi M, Nishino H: Striatal dopamine turnover during treadmill running in the rat: relation to the speed of running. Brain Res Bull 1994;35:41-9
  40. Wilson WM, Marsden CA: Extracellular dopamine in the nucleus accumbens of the rat during treadmill running. Acta Physiol Scand 1995;155:465-6
  41. Wang GJ, Volkow ND, Fowler JS, et al: PET studies of the effects of aerobic exercise on human striatal dopamine release. J Nucl Med 2000;41:1352-6
  42. Sarhill N, Walsh D, Nelson KA, et al: Methylphenidate for
  43. Grau JM, Casademont J, Pedrol E, et al: Chronic fatigue syndrome: studies on skeletal muscle. Clin Neuropathol 1992;11:329-32
  44. Byrne E, Trounce I: Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle. J Neurol Neurosurg Psychiatry 1987;50:743-6
  45. Kent-Braun JA, Miller RG, Weiner MW: Phases of metab- olism during progressive exercise to fatigue in human skeletal muscle. J Appl Physiol 1993;75:573-80
  46. McCully KK, Natelson BH: Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci (Lond) 1999; 97:603-8; discussion 611-3
  47. De Lorenzo F, Xiao H, Mukherjee M, et al: Chronic fatigue syndrome: physical and cardiovascular deconditioning. Q J Med 1998;91:475-81
  48. Lane RJ, Barrett MC, Woodrow D, et al: Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1998; 64:362-7
  49. Dehn MM, Bruce RA: Longitudinal variations in maximal oxygen intake with age and activity. J Appl Physiol 1972; 33:805-7
  50. Heath GW, Hagberg JM, Ehsani AA, et al: A physiological comparison of young and older endurance athletes. J Appl Physiol 1981;51:634-40
  51. Hughes VA, Frontera WR, Wood M, et al: Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol Ser A 2001;56:B209-17
  52. Bilodeau M, Henderson TK, Nolta BE, et al: Effect of aging on fatigue characteristics of elbow flexor muscles during sustained submaximal contraction. J Appl Physiol 2001; 91:2654-64
  53. Ditor DS, Hicks AL: The effect of age and gender on the relative fatigability of the human adductor pollicis muscle. Can J Physiol Pharmacol 2000;78781-90
  54. Kent-Braun JA, Ng AV, Doyle JW, et al: Human skeletal muscle responses vary with age and gender during fatigue due to incremental isometric exercise. J Appl Physiol 2002;93:1813-23
  55. Larsson L, Karlsson J: Isometric and dynamic endurance as a function of age and skeletal muscle characteristics. Acta Physiol Scand 1978;104:129-36
  56. Lindstrom B, Lexell J, Gerdle B, et al: Skeletal muscle fatigue and endurance in young and old men and women. J Gerontol A Biol Sci Med Sci 1997;52:B59-66
  57. Stackhouse SK, Stevens JE, Lee SC, et al: Maximum vol- untary activation in nonfatigued and fatigued muscle of young and elderly individuals. Phys Ther 2001;81:1102-9
  58. Davies CTM, White MJ: Effects of dynamic exercise on muscle function in elderly men, aged 70 years. Gerontol- ogy 1983;29:26-31
  59. Lennmarken C, Bergman T, Larsson J, et al: Skeletal muscle function in man: force, relaxation rate, endurance and contraction time-dependence on sex and age. Clin Physiol 1985;5:243-55
  60. Morley JE, Perry HM 3rd, Kaiser FE, et al: Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993;41: 149-52
  61. Sih R, Morley JE, Kaiser FE, et al: Testosterone replace- ment in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-7
  62. Bhasin S, Storer TW, Berman N, et al: Testosterone re- placement increases fat-free mass and muscle size in hy- pogonadal men. J Clin Endocrinol Metab 1997;82:407-13
  63. Bhasin S, Woodhouse L, Casaburi R, et al: Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005;90:678-88
  64. Urban RJ, Bodenburg YH, Gilkison C, et al : Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995;269: E820-6
  65. Brodsky IG, Balagopal P, Nair KS: Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 1996;81:3469-75
  66. Snyder PJ, Peachey H, Hannoush P, et al: Effect of testos- terone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647-53
  67. Schroeder ET, Terk M, Sattler FR: Androgen therapy im- proves muscle mass and strength but not muscle quality: results from two studies. Am J Physiol Endocrinol Metab 2003;285:E16-24
  68. Steidle C, Schwartz S, Jacoby K, et al: AA2500 testosterone gel normalizes androgen levels in aging males with im- provements in body composition and sexual function. J Clin Endocrinol Metab 2003;88:2673-81
  69. Bodenner DL, Medhi M, Evans WJ, et al: Effects of meges- trol acetate on pituitary function and end-organ hormone secretion: a post hoc analysis of serum samples from a 12-week study in healthy older men. Am J Geriatr Phar- macother 2005;3:160-7
  70. Lambert CP, Sullivan DH, Freeling SA, et al: Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin En- docrinol Metab 2002;87:2100-6
  71. Sullivan DH, Roberson PK, Johnson LE, et al: Effects of muscle strength training and testosterone in frail elderly males. Med Sci Sports Exerc 2005;37:1664-72
  72. Hajjar RR, Kaiser FE, Morley JE: Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997;82: 3793-6
  73. Alexandersen P, Haarbo J, Christiansen C: The relation- ship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996;125:1-13
  74. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994;14:701-6
  75. Zmuda JM, Cauley JA, Kriska A, et al: Longitudinal rela- tion between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year fol- low-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997;146:609-17
  76. Berg G, Schreier L, Geloso G, et al: Impact on lipoprotein profile after long-term testosterone replacement in hy- pogonadal men. Horm Metab Res 2002;34:87-92
  77. Whitsel EA, Boyko EJ, Matsumoto AM, et al: Intramuscu- lar testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 2001;111:261-9
  78. Morales A, Heaton JP, Carson CC 3rd: Andropause: A misnomer for a true clinical entity. J Urol 2000;163: 705-12
  79. Calof OM, Singh AB, Lee ML, et al: Adverse events associ- ated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-con- trolled trials. J Gerontol A Biol Sci Med Sci 2005;60: 1451-7
  80. Meredith CN, Frontera WR, Fisher EC, et al: Peripheral effects of endurance training in young and old subjects. J Appl Physiol 1989;66:2844-9
  81. Frontera WR, Meredith CN, O'Reilly KP, et al : Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 1988;64:1038-44
  82. Frontera WR, Meredith CN, O'Reilly KP, et al: Strength training and determinants of VO2 max in older men. J Appl Physiol 1990;68:329-33
  83. Campbell WW, Crim MC, Young VR, et al: Effects of resistance training and dietary protein intake on protein metabolism in older adults. Am J Physiol 1995;268: E1143-53
  84. Nelson ME, Fiatarone MA, Morganti CM, et al: Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. JAMA 1994;272:1909-14
  85. Shaw JM, Snow CM: Weighted vest exercise improves indices of fall risk in older women. J Gerontol A Biol Sci Med Sci 1998;53:M53-8
  86. Campbell WW, Crim MC, Young VR, et al: Increased en- ergy requirements and body composition changes with resistance training in older adults. Am J Clin Nutr 1994; 60:167-75
  87. Treuth MS, Hunter GR, Weinsier RL, et al: Energy expen- diture and substrate utilization in older women after strength training: 24-h calorimeter results. J Appl Physiol 1995;78:2140-6
  88. Fiatarone MA, Marks EC, Ryan ND, et al: High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 1990;263:3029-34
  89. Singh MA: Exercise comes of age: Rationale and recom- mendations for a geriatric exercise prescription. J Geron- tol Med Sci 2002;57:M262-82
  90. Evans WJ: Exercise as the standard of care for elderly people. J Gerontol A Biol Sci Med Sci 2002;57:M260-1
  91. Grinspoon S, Corcoran C, Rosenthal D, et al: Quantitative assessment of cross-sectional muscle area, functional sta- tus, and muscle strength in men with the acquired im- munodeficiency syndrome wasting syndrome. J Clin En- docrinol Metab 1999;84:201-6
  92. Sullivan PS, Dworkin MS: Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symp- tom Manage 2003;25:329-33
  93. Grinspoon S, Corcoran C, Lee K, et al: Loss of lean body and muscle mass correlates with androgen levels in hy- pogonadal men with acquired immunodeficiency syn- drome and wasting. J Clin Endocrinol Metab 1996;81: 4051-8
  94. Bhasin S, Storer TW, Javanbakht M, et al: Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2000; 283:763-70
  95. Grinspoon S, Corcoran C, Parlman K, et al: Effects of testosterone and progressive resistance training in eugo- nadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 2000;133:348-55
  96. Strawford A, Barbieri T, Van Loan M, et al: Resistance exercise and supraphysiologic androgen therapy in eugo- nadal men with HIV-related weight loss: a randomized controlled trial [see comments]. JAMA 1999;281:1282-90
  97. Sattler FR, Jaque SV, Schroeder ET, et al: Effects of phar- macological doses of nandrolone decanoate and progres- sive resistance training in immunodeficient patients in- fected with human immunodeficiency virus. J Clin Endocrinol Metab 1999;84:1268-76
  98. Mador MJ, Kufel TJ, Pineda LA, et al: Diaphragmatic fa- tigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:118-23
  99. Mador MJ, Bozkanat E: Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001; 2:216-24
  100. Mador MJ, Deniz O, Aggarwal A, et al: Quadriceps fatiga- bility after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:102-8
  101. Mador MJ, Bozkanat E, Aggarwal A, et al: Endurance and strength training in patients with COPD. Chest 2004;125: 2036-45
  102. Thompson JL, Butterfield GE, Marcus R, et al: The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995;80:1845-52
  103. Blackman MR, Sorkin JD, Munzer T, et al: Growth hor- mone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002;288:2282-92
  104. Hennessey JV, Chromiak JA, DellaVentura S, et al: Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 2001;49:852-8
  105. Rudman D, Feller AG, Nagraj HS, et al: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6
  106. Yarasheski KE, Campbell JA, Smith K, et al: Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992;262:E261-7
  107. Caruso JF, Signorile JF, Perry AC, et al: The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 1995;27:1471-6
  108. Kissel JT, McDermott MP, Mendell JR, et al: Randomized, double-blind, placebo-controlled trial of albuterol in fa- cioscapulohumeral dystrophy. Neurology 2001;57: 1434-40
  109. Kinali M, Mercuri E, Main M, et al: Pilot trial of albuterol in spinal muscular atrophy. Neurology 2002;59:609-10
  110. Uc EY, Lambert CP, Harik SI, et al: Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson disease. Clin Neu- ropharmacol 2003;26:207-12
  111. Winningham ML: Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer 2001; 92:988-97
  112. Lee JQ, Simmonds MJ, Wang XS, et al: Differences in physical performance between men and women with and without lymphoma. Arch Phys Med Rehabil 2003;84: 1747-52
  113. Helgeson VS, Tomich PL: Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 2005;14:307-17
  114. Servaes P, Verhagen S, Schreuder HW, et al: Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manage 2003;26:1113-22
  115. Kurzrock R: The role of cytokines in cancer-related fa- tigue. Cancer 2001;92:1684-8
  116. Tisdale MJ: Cancer anorexia and cachexia. Nutrition 2001; 17:438-42
  117. Tisdale MJ: Pathogenesis of cancer cachexia. J Support Oncol 2003;1:159-68
  118. Jeejeebhoy EN: Muscle function and nutrition. Gut 1986; 27:25-39
  119. Abels RI: Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Acta Haematol 1992;87 (Suppl 1):4-11
  120. Henry DH, Abels RI: Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Semin Oncol 1994;21:21-8
  121. Demetri GD, Kris M, Wade J, et al: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is inde- pendent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998;16:3412-25
  122. Glaspy J, Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997;15:1218-34
  123. Jones M, Schenkel B, Just J, et al: Epoetin alfa improves quality of life in patients with cancer: results of metaanaly- sis. Cancer 2004;101:1720-32
  124. Lundin AP, Akerman MJ, Chesler RM, et al: Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991;58:315-9
  125. Metra M: Improvement in exercise capacity after correc- tion of anemia in patients with end-stage renal failure. Am J Cardiol 1991;68:1060-6
  126. Akiba T: Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis pa- tients. Artificial Organs 1995;19:1262-8
  127. Daneryd P, Svanberg E, Korner U, et al: Protection of metabolic and exercise capacity in unselected weight-los- ing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res 1998;58:5374-9
  128. Schwartz AL, Thompson JA, Masood N: Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 2002;29:E85-90
  129. Breitbart W, Rosenfeld B, Kaim M, et al: A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001;161:411-20
  130. Chlebowski RT, Herrold J, Ali I, et al: Influence of nan- drolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986;58:183-6
  131. Convertino V, Olsen L, Goldwater D, et al: Cardiorespira- tory responses to exercise after bed rest in 45 to 55 year old men and women. Aerospace Med Assoc Preprints 1979: 26-7
  132. Convertino VA, Bisson R, Bates R, et al: Effects of anti- orthostatic bedrest on the cardiorespiratory responses to exercise. Aviation Space Environ Med 1981;52:251-5
  133. Krasnoff J, Painter P: The physiological consequences of bed rest and inactivity. Adv Ren Replace Ther 1999;6: 124-32
  134. Saltin B, Blomqvist G, Mitchell JH, et al: Response to exercise after bed rest and after training. Circulation 1968; 38:VII1-78
  135. Dimeo FC: Effects of physical activity on the fatigue and psychologic status of cancer patients during chemother- apy. Cancer 1999;85:2273-7
  136. Schwartz AL, Mori M, Gao R, et al: Exercise reduces daily fatigue in women with breast cancer receiving chemother- apy. Med Sci Sports Exercise 2001;33:718-23
  137. Segal R, Evans W, Johnson D, et al: Structured exercise improves physical functioning in women with stages I and II breast cancer: Results of a randomized controlled trial. J Clin Oncol 2001;19:657-65
  138. Dimeo F, Rumberger BG, Keul J: Aerobic exercise as therapy for cancer fatigue. Med Sci Sports Exercise 1998; 30:475-8
  139. Windsor PM, Nicol KF, Potter J: A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for lo- calized prostate carcinoma. Cancer 2004;101:550-7
  140. Dimeo FC: Effects of exercise on cancer-related fatigue. Cancer 2001;92:1689-3
  141. Brutsche MH, Spiliopoulos A, Bolliger CT, et al: Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J 2000;15:828-32
  142. Miyoshi S, Nakahara K, Ohno K, et al: Exercise tolerance test in lung cancer patients: the relationship between exercise capacity and postthoracotomy hospital mortality. Ann Thoracic Surg 1987;44:487-90
  143. Kolden GG, Strauman TJ, Ward A, et al: A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psychooncol- ogy 2002;11:447-56